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The differential effects of the gonadotropin receptors on
aromatase expression in primary cultures of immature rat
granulosa cells are highly dependent on the density of receptors
expressed and the activation of the inositol phosphate cascade*
Francesc Xavier Donadeu and Mario Ascoli
Department of Pharmacology, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242
Abstract
Signaling pathways mediating the divergent effects of FSH and LH on aromatase in immature rat
granulosa cells were studied by infecting cells with increasing amounts of adenoviral vectors for the
hLHR or hFSHR. Increasing amounts of Ad-hLHR, used at a multiplicity of infection (MOI) of 20
or 200 viable viral particles/cell increased hCG binding, hCG-induced cAMP and Akt
phosphorylation but inositol phosphates only increased in response to hCG in cells infected with 200
MOI Ad-hLHR. In contrast hCG increased aromatase expression in cells infected with 20 but not in
cells infected with 200 MOI Ad-hLHR. Cells infected with 20 or 200 MOI Ad-hFSHR showed
increased hFSH binding and hFSH-induced Akt phosphorylation, but the hFSH-induced cAMP
response was unchanged relative to control cells. However, hFSH was able to stimulate the inositol
phosphate cascade in the Ad-hFSHR infected cells, and the hFSH induction of aromatase was
abolished. We also found that activation of C kinase or expression of a constitutively active form of
Gαq inhibited the induction of aromatase by hFSH or 8Br-cAMP.
We conclude that the differential effects of FSH and LH on aromatase in immature granulosa cells
are highly dependent on gonadotropin receptor density and on the signaling pathways activated. We
propose that aromatase is induced by common signals generated by activation of the FSHR and LHR
(possibly cAMP and Akt) and that the activation of the inositol phosphate cascade in cells expressing
a high density of LHR or FSHR antagonizes this induction.
Introduction
The development of ovulatory follicles involves the differentiation of their granulosa cell
component from a mitotically active, estrogen-secreting type (immature cells) into a non-
dividing, luteinized, progesterone-secreting type (mature cells). Granulosa cell differentiation
is regulated by two pituitary hormones, luteinizing hormone (LH) and follicle stimulating
hormone (FSH) as well as intra-ovarian steroids and growth factors (reviewed in refs. 1,2,3).
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The receptors for FSH (FSHR) and LH (LHR) are members of the G-protein coupled family
of receptors (GPCR) and their expression in granulosa cells depends on the stage of cell
differentiation. The FSHR is expressed in both immature and mature cells, but the LHR is
expressed only in the mature cell type. In immature granulosa cells, FSH promotes cell
multiplication and induces the expression of aromatase and the LHR. In contrast, in mature
cells the ovulatory LH surge results in cell cycle arrest, suppression of aromatase and LHR
expression, increased progesterone synthesis and luteinization. These divergent effects of LH
and FSH stand in contrast with the high degree of amino acid sequence homology between the
two hormones (4–6) and between their two receptors (6–10), and with the fact that both the
LH/LHR and the FSH/FSHR complexes use the Gs/adenylyl cyclase/cAMP as their main
signaling pathway (6–10).
The reasons for the divergent actions of the LH/LHR and the FSH/FSHR pairs on granulosa
cells in spite of their structural and functional similarities are not fully understood. Explanations
put forward to explain these divergent actions include the expression of the LHR and FSHR
at different stages of granulosa cell differentiation, differences in the properties (magnitude,
duration, compartmentalization, etc) of the common cAMP signal, or differences in the
generation of other intracellular signals by the two hormone/receptor pairs (2,3,11,12). On the
other hand, the differential effects of FSH and LH may simply reflect differences in hormone
levels or in receptor density. For example, in FSH-primed immature rat granulosa cells sub-
ovulatory doses of LH can stimulate estrogen synthesis and LHR expression in a manner similar
to FSH (13,14). Moreover, in estrogen-primed rats high doses of FSH can have the same effects
as those seen with an ovulatory LH surge, i.e., induction of ovulation and luteinization (15).
An important technical advance in the understanding of the divergent actions of LH and FSH
in the ovary is the use of adenoviral vectors to induce expression of the recombinant hLHR in
primary cultures of immature rat granulosa cells. Using this experimental approach it has been
shown that two of the hallmark responses of FSH action (i.e., the induction of aromatase and
the LHR) are likely due to differences in the signaling properties of the LHR and the FSHR
rather than to their expression at different stages of maturation of the granulosa cells (16,17).
It has also been concluded that the ability of FSH to stimulate aromatase and LHR expression
involves the activation of the PKB/Akt signaling pathway (17) in addition to the cAMP
pathway (1–3,11,12,18–23).
In the experiments presented here we used adenovirus-directed expression of hLHR and
hFSHR in primary cultures of immature rat granulosa cells to determine the receptor-activated
pathways that may account for the divergent effects of FSH and LH in granulosa cells and to
determine the effects of receptor density on the signaling properties of each receptor. We tested
the hypothesis that the differential effects of FSH and LH on aromatase expression are due to
the activation of a common stimulatory signaling pathway involving cAMP and an inhibitory
signaling pathway that involves inositol phosphates and is uniquely activated by LH. Rationale
for this comes from the observations that, (a) addition of hCG to cells expressing a high density
of the LHR is able to stimulate not only cAMP but also inositol phosphates (reviewed in ref.
24); and (b) pharmacological activation of protein kinase C (PKC) antagonizes the effects of
FSH or cAMP on the expression of aromatase and several other ovarian genes (25–28).
In doing these experiments we also found, unexpectedly, that the functional properties of the
FSHR are modified by the co-expression of increasing densities of the LHR.
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Materials and Methods
Plasmids, viruses and cells
The myc-tagged versions of the hLHR (29) and hFSHR (30) were subcloned by us into the
RAPAd™ adenoviral vector. A constitutively active mutant of Gαq (Q209L) that has reduced
capacity to hydrolyze GTP (31–33) was obtained from the Guthrie Research Center (http://
www.guthrie.org/AboutGuthrie/Research/CDNA/) and subcloned in the same vector. The
recombinant adenoviral particles (Ad-hLHR, Ad-hFSHR and Ad-GqQ209L) as well as
recombinant adenoviral particles coding for β–galactosidase (Ad-βgal) were prepared by the
Gene Transfer Vector Core of the University of Iowa (http://www.uiowa.edu/~gene/
vectors.htm).
Granulosa cells from immature (25-days old) female Sprague-Dawley rats that had been treated
with diethylestilbestrol (DES; 2 mg/day, injected subcutaneously in 200 μl of sesame oil) for
4 days were collected by ovarian puncture as described by others (34). These procedures were
approved by the Institutional Animal Care and Use Committee for the University of Iowa. Cells
were plated in 24-well plates (0.25 million cells/well) or 12-well plates (0.5 million cells/well)
that had been pre-coated with bovine fibronectin. The cells were incubated at 37 C in culture
medium consisting of DMEM/F12 medium (1:1, vol:vol) containing 10 mM HEPES, 50 μg/
ml Gentamicin, 0.1% bovine serum albumin and supplemented with insulin (1 μg/ml),
transferrin (1 μg/ml) and selenium (1 ng/ml ; ITS), as described elsewhere (20,35). Two days
after plating, the cells were incubated in culture medium without bovine serum albumin and
ITS and containing the recombinant adenovirus for 2 hours at 37C. Cells infected with Ad-
βgal at a multiplicity of infection (MOI) of 200 were used as controls. Other experimental
groups included cells infected with Ad-hLHR or Ad-hFSHR at an MOI of 200, and cells
infected with a mixture of the Ad-hLHR or Ad-hFSHR (at 20 MOI) and Ad-βgal (at 180 MOI).
These conditions allowed us to keep a constant viral load while changing the amount of
recombinant receptors expressed. When needed, the Ad-GqQ209L construct was used (0.5
MOI) in combination with Ad-βgal (199.5 MOI). At the end of the two-hour incubation with
the viral particles the virus-containing medium was removed and replaced with culture
medium. In all cases, infected cells were incubated at 37 C for two days before use in the assays
described below. The expression of the recombinant receptors was shown to be optimal or near
optimal after this 2-day incubation (data not presented).
Binding Assays
Cells in 12-well plates were washed and placed in 0.5 ml of assay medium (DMEM/F12
medium (1:1, vol:vol) containing 10 mM HEPES, 50 μg/ml Gentamicin, and 0.1% bovine
serum albumin). Duplicate wells were incubated with 125I-hCG or 125I-FSH (100 ng/ml) for
4 h at 37 C. Nonspecific binding was determined by incubating one additional well with the
same concentration of 125I-hCG or 125I-FSH plus crude hCG (50 IU/ml) or eFSH (5 μg/ml),
respectively. After incubation, cells were washed two times with assay medium, lysed with 50
μl of 0.5 N NaOH, and then collected with a cotton swab and counted in a γ-counter. The
conditions chosen for these binding assays were shown to result in maximal hormone binding
(data not shown).
Second messenger assays
To measure production of cAMP, cells in 24-well plates were washed two times with DMEM/
F12 medium (1:1, vol:vol) containing 10 mM HEPES, 50 μg/ml Gentamicin, 0.1% bovine
serum albumin and supplemented with 0.5 mM isobutylmethylxanthine and then incubated at
37 C for 15 min in 0.25 ml of the same medium. Triplicate wells were then incubated with
hFSH (100 ng/ml), hCG (100 ng/ml) or buffer at 37 C for an additional 30 min after which
total cAMP (i.e., cells + medium) was extracted and measured by RIA as described before
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(36). Under these conditions cAMP accumulation attains a maximal or near maximal level
within 30 min of hormone addition and remains elevated for at least 4 hours (30,37,38). The
concentrations of hormones used were also chosen to elicit maximal cAMP accumulation
(30,37,38).
To measure the accumulation of inositol phosphates, cells in 12-well plates were washed once
with inositol-free DMEM containing 10 mM Hepes, 50 μg/ml gentamicin and 0.1% bovine
serum albumin and then placed in 0.5 ml of the same medium containing 4 μCi/ml of [2-3H]
myo-inositol (NEN Life Science Products, Boston, MA) during the last 18-h of the post-
infection incubation. Cells were then washed two times with DMEM/F12 medium (1:1,
vol:vol) containing 10 mM HEPES, 50 μg/ml Gentamicin, 0.1% bovine serum albumin and
supplemented with 20 mM LiCl and incubated in 0.5 ml of the same medium at 37 C for 15
min. This was followed by an additional 60-min incubation in the presence of hFSH (500 ng/
ml), hCG (500 ng/ml) or buffer. Inositol phosphates were then extracted and quantitated as
described (39). These conditions have been shown to result in maximal or near maximal inositol
phosphate accumulation in cells expressing the recombinant gonadotropin receptors (30,37,
38). The concentrations of hormones used were also chosen to elicit maximal inositol phosphate
accumulation (30,37,38,40).
Akt phosphorylation assays
Cells in 12-well plates were washed twice with DMEM/F12 medium (1:1, vol:vol) containing
10 mM HEPES, 50 μg/ml gentamicin and 0.1% bovine serum albumin and placed in 1 ml of
the same medium during the last 18-h of the post-infection incubation. The medium was then
replaced with 0.5 ml of the same medium and the cells were incubated for 30 min in the presence
of hFSH (100 ng/ml), hCG (100 ng/ml) or buffer only. At the end of the incubation the cells
were placed on ice, quickly washed twice with 1 ml of cold buffer containing 150 mM NaCl
and 20 mM HEPES (pH 7.4) and lysed with 35 μl of lysis buffer (150 mM NaCl, 50 mM Tris,
1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM Na3VO4, 1 mM NaF,
pH 7.4) by gentle rocking at 4 C for 30 min. The resulting lysates were clarified by
centrifugation and assayed for protein content using the BCA protein assay kit from Bio-Rad
Laboratories Inc. (Hercules, CA). Thirty μg of protein from each lysate were then resolved on
12% polyacrylamide gels and transferred electrophoretically to polyvinylidene difluoride
membranes (40). This was followed by an overnight incubation of the membranes in a 1:3000
dilution of a phospho-AKT (Ser473) antibody (Cell Signaling Technology Inc, Beverly, MA)
followed by a second 1 h incubation with a 1:3000 dilution of a secondary antibody covalently
coupled to horseradish peroxidase (Bio-Rad Laboratories Inc.,Hercules, CA). Finally, immune
complexes were visualized and quantified using the Super Signal West Femto Maximum
Sensitivity detection system (Pierce Chemical Inc, Rockford, IL) and a Kodak digital imaging
system (Eastman Kodak Co., Rochester, NY). The effects of hCG and hFSH on the
phosphorylation of Akt are transient (41,42) and our time course experiments (not shown)
revealed that a 30-min incubation with hCG or hFSH was optimal for the detection of this
response. The concentrations of hormones used for the Akt phosphorylation assays were also
chosen to elicit a maximal response (data not shown).
Quantitation of mRNA by Real-time PCR
Two days after infection, medium was aspirated and cells were incubated at 37 C for an
additional 48 h with fresh culture medium supplemented with 50 ng/ml testosterone and
containing hFSH (100 ng/ml), hCG (100 ng/ml), 8BrcAMP (1 mM) and/or phorbol 12-
myristate-13-acetate (PMA, 100 nM). Total RNA was then extracted using Trizol reagent and
chloroform followed by isopropanol precipitation. One μg of collected total RNA was reverse-
transcribed using Superscript III and random primers (p(dN)6). Aromatase cDNA in the reverse
transcription product was quantitated by real time PCR (43) using Sybr Green (Sybr Green
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PCR Master Mix; Applied Biosystems, Foster City, CA) for amplicon detection and ROX as
an internal reference dye. Standard PCR settings (50 C for 2 min, 95 C for 10 min and 40 cycles
of 95 C for 15 s and 60 C for 1 min) were used in an ABI Prism 7000 Sequence Detection
System (Applied Biosystems, Foster City, CA). Specific primers (forward,
TCCTCCTGATTCGGAATTGTG; reverse, GGCCCGATTCCCAGACA) were used for the
reaction. The amount of aromatase mRNA was calculated using ABI Prism 7000 Sequence
Detection System software (Applied Biosystems, Foster City, CA). Briefly, a cycle threshold
(CT; the first cycle at which a detectable increase in the target amplicon is observed) was
obtained for each sample and used to calculate the amount of aromatase mRNA relative to a
standard curve (43). GAPDH mRNA was also quantitated in the same samples using specific
primers (forward, TGCCAAGTATGATGACATCAAGAAG; reverse,
AGCCCAGGATGCCCTTTAGT) and used to correct for variations in RNA content among
samples. The 48-hour incubation chosen for the aromatase expression experiments was chosen
based on our data (not shown) and those of others (16,17,23) who have previously studied this
phenomenon.
Statistical methods
To account for experimental variability, within each experiment and endpoint (except for
binding data) all values were calculated relative to the value obtained in cells infected with 200
MOI Ad-βgal and treated with FSH (which was taken as 1.0) and are thus shown in the
corresponding graphs. Data were then analyzed using the SAS Mixed Procedure (44) and
Tukey’s tests were used for comparisons among means. In all cases statistical significance was
considered at P < 0.05.
Materials
Purified hCG (CR-127, ~13,000 IU/mg) and purified hFSH (AFP-5720D) were purchased from
Dr. A. Parlow of the National Hormone and Pituitary Agency.. Purified recombinant hCG and
hFSH were kindly provided by Ares Serono (Randolph, MA). 125I-hCG and 125I-hFSH were
prepared as described elsewhere (45). Partially purified hCG (~3,000 IU/mg), purchased from
Sigma (St. Louis, MO), and partially purified eFSH, kindly donated by Dr. George Bousfield
(Wichita State University, Wichita, KS), were used only for the determination of nonspecific
binding (see above). The cAMP antibody and 125I-cAMP used for the cAMP assays were as
described before (46). Cell culture medium was obtained from Invitrogen Corp. (Carlsbad,
CA). Other supplies and reagents used for granulosa cell extraction and culture were obtained
from Sigma-Aldrich Corp. (St Louis, MO), BD Biosciences (San Jose, CA) or Corning
(Corning, NY). 8Br-cAMP, PMA and testosterone were obtained from Sigma-Aldrich Corp.
(St. Louis, MO). Molecular biology reagents were obtained from Invitrogen Corp. (Carlsbad,
CA) or Roche Diagnostics Corp. (Indianapolis, IN). All other chemicals were obtained from
commonly used suppliers.
Results
We chose to use adenoviral vectors to induce the expression of recombinant gonadotropin
receptors in immature rat granulosa cells because they have shown to mediate high levels of
recombinant protein expression in these cells (90% of infected cells) without adversely
compromising cellular function (16,47). Infection with the Ad-hLHR or Ad-hFSHR constructs
resulted in the expression of the recombinant receptor as indicated by increased binding
of 125I-hCG or 125I-hFSH, respectively (Figures 1 and 5). In addition, the recombinant
receptors were functional, as shown by the cAMP, inositol, phospho Akt (Figures 2 and 6),
and aromatase (Figures 3 and 7) responses induced upon receptor activation with hCG or hFSH.
All of these responses were measured using a saturating hormone concentration (see Materials
and Methods) and a single time point. The time points and other experimental conditions
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selected to measure the different responses are different and they were chosen to provide
optimal conditions for measuring each of these individual responses (see Materials and
Methods and individual figure legends).
As expected, primary cultures of immature rat granulosa cells infected with a control
adenovirus coding for β-galactosidase (Ad-βgal) bound 125I-hFSH but did not bind 125I-hCG
(Figure 1, white bars in left and right panels). The binding of 125I-hCG dramatically increased
in cells infected with 200 MOI Ad-hLHR (Figure 1, right panel) and this increase was
associated with increases in the hCG-induced cAMP, inositol phosphate and phospho Akt
responses (Figure 2a b and c, right panels). 125I-hCG binding (Figure 1, right panel) in the 20
MOI Ad-hLHR-infected cells was measurable (~0.5 ng/106 cells) but was low compared to
binding in 200 MOI Ad-hLHR-infected cells (~3 ng/106 cells), and it was not statistically
different from that in the control cells (~0.05 ng/106 cells). However, the clear hCG-induced
cAMP and Akt phosphorylation responses observed in the cells infected with 20 MOI Ad-
hLHR relative to control cells (Figures 2a and c, right panels) reassured us that the 20 MOI
viral load was indeed inducing the expression of functional hLHR. We attribute the different
results obtained with these three methods to the higher sensitivity of the cAMP and Akt
phosphorylation assays. In interpreting these and all subsequent data it is important to note that
the levels of expression of the recombinant LHR in cells infected with the Ad-hLHR are
comparable to those attained when the expression of the endogenous LHR is induced by
stimulation of these cells with FSH or 8-BrcAMP (35). Immature rat granulosa cells maintained
for 3 days under the same culture conditions used here but in the presence of maximally
effective concentrations of FSH or 8Br-cAMP bind 1–4 ng of 125I-hCG/106 cells when binding
is assayed under the same conditions used here (35).
As mentioned above hCG-induced cAMP and phospho Akt responses were readily measurable
in cells infected with 20 or 200 MOI Ad-hLHR (Figures 2a and c, right panels). The hCG-
induced cAMP response increased as receptor expression increased (Figure 2a, right panel)
but the Akt response was already maximal in cells infected with 20 MOI Ad-hLHR (Figure
2c, right panel). In contrast, only cells expressing the highest density of hLHR (i.e., those
infected with 200 MOI Ad-hLHR) responded to hCG with a significant increase in inositol
phosphates (Figure 2b, right panel). This is in agreement with results obtained in a number of
LHR-transfected cell lines where it has been shown that an inositol phosphate response to hCG
stimulation is detectable only at high levels of LHR expression (24). A clear effect of hCG on
the induction of aromatase expression was only detected after hCG stimulation of 20 MOI
hLHR-infected cells (Figure 3, right panel). The hCG-induced aromatase expression in the
cells infected with 200 MOI hLHR was about 85% lower than that detected in the 20 MOI
hLHR-infected cells and it was not statistically different from the aromatase response detected
in hCG-stimulated control cells (Figure 3, right panel).
To gain insight into the signaling mechanisms involved in the effects of the activated
recombinant hLHR on aromatase, we compared the signaling and gene expression responses
elicited by hCG in Ad-hLHR-infected cells to those elicited by hFSH in Ad-βgal-infected cells,
which express the endogenous FSHR (see white bar on the left panel of Figure 1). As expected,
activation of the endogenous FSHR with hFSH induced increases in cAMP levels and Akt
phosphorylation (see white bars in the middle panels of Figures 2a and c). Activation of the
endogenous FSHR did not result in any detectable accumulation of inositol phosphates,
however (see white bar in the middle panel of Figure 2b). The increase in cAMP accumulation
was of similar magnitude to that induced by hCG in 200 MOI hLHR-infected cells (compare
the white bar in the middle panel with the black bar in the right panel of Figure 2a), and the
increase in phospho Akt was less than that induced by hCG in 20 or 200 MOI hLHR-infected
cells (compare the white bar in the middle panel with the gray and black bars in the right panel
of Figure 2c). In addition, the activation of the endogenous FSHR resulted, as expected, in an
Donadeu and Ascoli Page 6
Endocrinology. Author manuscript; available in PMC 2005 October 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
increase in aromatase mRNA and this increase was of similar magnitude to the increase in
aromatase induced by hCG in the 20 MOI hLHR-infected cells (compare white bar in the
middle panel with the gray bar in the right panel in Figure 3). These data clearly support the
hypothesis that aromatase can be induced by a common signal or signals (either cAMP alone
or a combination of cAMP and phospho Akt) generated by activation of the FSHR and LHR
and that a second signal selectively generated by activation of high densities of the LHR
antagonizes this induction. Our results (Figure 2b) are also consistent with the hypothesis that
the inositol phosphate cascade is this inhibitory signal generated by activation of the LHR when
expressed at a high density.
To more directly test the involvement of the activation of the inositol phosphate cascade in the
LHR-induced inhibition of aromatase expression, we used Ad-βgal-infected immature
granulosa cells to examine the effects of mutational activation of Gαq or pharmacological
activation of protein kinase C on aromatase induction by hFSH or 8Br-cAMP (Figure 4). A
construct coding for a constitutively active Gαq mutant (GqQ209L) that strongly activates the
inositol phosphate cascade (48) was used at a viral load that induced levels of inositol
phosphates similar to those induced by activation of the hLHR in 200 MOI hLHR-infected
cells (Table 1 and Figure 2b, right panel) and did not affect 125I-hFSH binding or the hFSH-
induced cAMP response (Table 1). As shown in Figure 4, 8Br-cAMP induced an increase in
aromatase mRNA of similar magnitude to that induced by hFSH and both of these increases
were reduced in cells infected with Ad-GqQ209L (Figure 4). In agreement with previous results
(26) we also found that pharmacological activation of protein kinase C with PMA diminished
the stimulatory effects of hFSH or 8Br-cAMP on aromatase expression (Figure 4). Thus,
activation of the inositol phosphate cascade by expression of the constitutively active Gαq or
activation of PKC (one of the two branches of this cascade) is sufficient to inhibit the induction
of aromatase by hFSH or 8Br-cAMP. These results further indicate that the differential effects
of FSH and hCG on the induction of aromatase shown in Figure 3 are mediated by the
preferential hLHR-induced activation of the inositol phosphate cascade in cells expressing high
densities of hLHR. Furthermore we conclude that this effect is mediated (at least in part) by
the activation of PKC because it can be reproduced by pharmacological activation of this
kinase.
Because the expression of increasing densities of the hLHR in immature granulosa cells could
potentially affect the expression and signaling properties of the endogenous FSHR it is also
important to investigate this possibility. This is an important issue because endogenous LHR
expression increases as granulosa cells differentiate in vivo (49) and the effects of this increase
in LHR density on signaling by the co-expressed endogenous FSHR have not been studied.
Interestingly, our data show that expression of increasing densities of the recombinant hLHR
affects some aspects of hFSH-induced signaling in these cells. Increased expression of the
hLHR had no effect on the binding of 125I-hFSH to the endogenous FSHR (see left panel of
Figure 1) or the hFSH-induced phospho Akt response (see middle panel of Figure 2c). There
was, however, a ~25% reduction in the hFSH-induced cAMP response in 200 MOI hLHR-
infected cells relative to Ad-βgal-infected cells (see middle panel of Fig 2a), as well as a
reduction in the hFSH-induced aromatase mRNA in cells infected with 20 MOI hLHR or 200
MOI hLHR (41% and 87%, respectively; see middle panel of Figure 3). Thus, the expression
of the recombinant, non activated hLHR directly or indirectly impaired the ability of hFSH to
induce aromatase mRNA, and this seemed to involve, at least partially, a decrease in FSHR-
stimulated cAMP production.
Since the density of the recombinant hLHR expressed in 200 MOI Ad-hLHR infected cells is
3- to 4-fold higher than the density of the endogenous FSHR (compare the white bar in the left
panel and the black bar in the right panel of Figure 1) it was also important to determine if the
functional properties of the FSHR change as the density of the FSHR increases. This issue was
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addressed by analyzing the actions of hFSH and hCG in immature granulosa cells infected with
increasing amounts of an adenovirus coding for the hFSHR (Figures 5–7). Infection with 20
or 200 MOI Ad-hFSHR resulted in a ~4- and ~16-fold increase in 125I-hFSH binding,
respectively, relative to Ad-βgal-infected cells, which express only the endogenous FSHR
(Figure 5, left panel). These increased levels of hFSHR had no effect on the hFSH-induced
cAMP response (Figure 6a, middle panel)1 but they elicited a detectable increase in the hFSH-
induced inositol phosphate (Figure 6b, middle panel) and they enhanced the hFSH-induced
phospho Akt response (Figure 6c, middle panel). Although the magnitude of the phospho Akt
response observed in cells expressing the recombinant hFSHR is similar to that mediated by
the recombinant hLHR (compare the middle panel of Figure 6c with the right panel of Figure
2c), the magnitude of the inositol phosphate response is lower than that mediated by the
recombinant hLHR, especially when receptor density is taken into account. Thus, whereas
granulosa cells infected with 200 MOI of Ad-hLHR bound ~3 ng 125I-hCG/106 cells (Figure
1, right panel) and responded to hCG with a ~4-fold increase in inositol phosphates (Figure
2b, right panel), cells infected with 20 or 200 MOI of Ad-hFSHR bound ~4 or ~16 ng 125I-
hFSH/106 cells, respectively (Figure 5, left panel) and responded to hFSH with only a ~2-fold
increase in inositol phosphate accumulation (Figure 6b, middle panel). Interestingly, at these
high levels of hFSHR expression the ability of hFSH to induce aromatase expression was
drastically reduced when compared to the cells infected with Ad-βgal (Figure 7, middle panel)
in spite of the unchanged hFSH-induced cAMP response (Figure 6a, middle panel) and the
enhanced phospho Akt response (Figure 6c, middle panel). Thus, these results are also
consistent with the hypothesis that activation of the inositol phosphate cascade (which in this
case is mediated by engaging the increased levels of the recombinant hFSHR with hFSH) is
responsible for a decrease in the ability of hFSH to induce aromatase expression.
Finally, the effects of Ad-hFSHR infection on endogenous LHR expression and signaling were
evaluated in immature rat granulosa cells. As shown in the right panels of Figures 5–7, the
increased expression of hFSHR did not affect 125I-hCG binding or hCG-induced cAMP, -
inositol phosphate, -phospho AKT or -aromatase mRNA.
Discussion
The identification of the signaling mechanisms underlying the differential effects of FSH and
LH on granulosa cells has been considerably limited by the expression of the endogenous LHR
and FSHR at different stages of granulosa cell differentiation. Thus, when studying the
signaling pathways activated by the endogenous gonadotropin receptors present in granulosa
cells a distinction cannot be made between differences in signaling due to receptor type or to
changes in the intracellular signaling milieu, i.e., steroidogenic enzymes and signaling proteins,
that may occur as a consequence of the differentiation of the granulosa cells.
The observation that high levels of recombinant protein expression can be induced in rat
immature granulosa cells by using adenoviral vectors (47) obviated this problem as it allowed
for the expression of the recombinant LHR in these cells (16,17). Here we used adenoviral
vectors to express the recombinant hLHR and hFSHR in immature rat granulosa cells and to
study the effects of both receptor type and receptor density on signaling pathways and
aromatase expression. In agreement with the results of others (16), we conclude that the
1The lack of effect of increasing hFSHR expression on the hFSH-induced cAMP response was not further investigated. Receptor/G
protein-mediated responses are dictated by the levels of receptors and their cognate G proteins as well as their affinity for each other and
they can saturate as the levels of receptors increase (50). It is possible that the endogenous FSHR has a high affinity for Gs and that this
interaction is already saturated. Alternatively, Gs may not be saturated but additional G proteins that antagonize the actions of Gs on
adenylyl cyclase (such as Gi/o) may be engaged by increasing levels of the recombinant hFSHR and these may prevent the expected
enhancement in cAMP accumulation.
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differential actions of the LH/CG and FSH on granulosa cells are not due to the stage of cell
differentiation.
Importantly, our results show that the effects of LHR and FSHR activation on aromatase
expression in immature granulosa cells are highly dependent on receptor density and signaling
pathways activated. We show that, when expressed at low densities, the activated hLHR can
induce aromatase expression to a similar extent as that observed when the endogenous FSHR
is activated. When expressed at high densities, however, the activated hLHR is unable to induce
aromatase expression. This finding, that the effects of hCG on aromatase expression are
dependent on the density of the hLHR expressed is in agreement with previous data showing
that a biphasic aromatase response occurs with increasing doses of hCG in cultured
differentiated granulosa cells expressing the endogenous LHR (21,23,51). In this system low
concentrations of hCG stimulate aromatase expression to a similar extent as a maximally
effective concentration of FSH whereas higher concentrations of hCG do not stimulate
aromatase expression. Our findings underscore the physiological importance of the progressive
increase in the density of LHR that occurs during granulosa cell differentiation (49).
The data presented here also show for the first time that with increasing densities of hFSHR
the induction of aromatase by the activated FSHR declines substantially (Figure 7). Several
studies (15,52,53) reported that ovulatory surge doses of FSH have LH-surge like effects in
estradiol-primed, hypophysectomized rats or mice, i.e., they induce follicular luteinization and
ovulation. Thus, as for the LHR, opposing effects in granulosa cells result from low FSHR
densities/low FSH concentrations and high FSHR densities/high FSH concentrations. Since
the type of signaling pathways activated by GPCRs may vary as the density of receptors or the
amount of agonist used increase (54) we hypothesize that at low signal strengths (i.e., low
receptor density and/or agonist concentration) the LHR and FSHR activate a common signaling
pathway (or pathways) that is/are stimulatory to the expression of aromatase and that at high
signal strengths (i.e., high receptor density and/or agonist concentration) they also activate
(similar or distinct) signaling pathways that are inhibitory to the expression of aromatase.
The adenylyl cyclase/cAMP pathway is likely to represent a common pathway activated by
the LHR and FSHR that is involved in the induction of aromatase. All investigators agree that
the LHR and the FSHR activate this signaling system (6–10) and that addition of cAMP
analogs, or the receptor-independent activation of the cAMP signaling system, can induce the
expression of aromatase in granulosa cells (1–3,11,12,18,19,21–23). The data presented here
are consistent with this hypothesis. When exposed to a maximally effective concentration of
hFSH, the density of endogenous FSHR present in immature granulosa cells is already high
enough to mediate maximal cAMP accumulation and is optimal for hFSH-induced aromatase
expression. An increase in the density of FSHR elicited by infection with Ad-hFSHR does not
increase the magnitude of the hFSH-induced cAMP response but it substantially reduces the
induction of aromatase by hFSH (see Figures 5–7), presumably because of the simultaneous
activation of an opposing pathway. When immature granulosa cells are infected with Ad-hLHR
the optimal induction of aromatase by hCG occurs at a low density of recombinant hLHR when
the magnitude of the hCG-induced cAMP response is lower than that induced by hFSH acting
through the endogenous FSHR (see Figures 1–3). As the density of the recombinant hLHR
increases the magnitude of the hCG-induced cAMP response also increases but the hCG-
induced aromatase expression decreases substantially (see Figures 1–3), again, because of the
presumed, simultaneous activation of an opposing pathway.
In view of our results and those of others (17,41,42) one must also consider the possibility that
the phosphorylation of Akt represents an additional, common pathway activated by the LHR
and FSHR that, together with cAMP, is involved in the induction of aromatase. Others have
previously shown that injection of hCG results in Akt phosphorylation in the ovaries of rats in
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diestrus (42) and we have shown here that hCG-increases Akt phosphorylation in immature
granulosa cells expressing increasing densities of the recombinant hLHR (Figure 2c). FSH,
acting through the endogenous FSHR has also been reported to increase Akt phosphorylation
(41,55). We have confirmed those results here and have also shown that increased expression
of the recombinant hFSHR enhances this response (Figure 6c). The involvement of the Akt
pathway on the FSH-induced expression of aromatase is supported by the ability of a dominant
negative form of Akt to diminish this effect of FSH (17). In addition, Akt overexpression was
shown to potentiate the induction of aromatase by FSH, cAMP and a constitutively active form
of the LHR (17).
Since there is general agreement that the inositol phosphate cascade is activated when the LHR
is expressed at high densities and exposed to high concentrations of hCG (see Figures 1 and 2
and reference 24) and since the activation of this pathway is inhibitory to the cAMP- and FSH-
induced aromatase expression (Figure 4 and ref. 26) we propose that the LH/CG-induced
activation of the inositol phosphate cascade is responsible for the decrease in aromatase
induction observed at high densities of the LHR (Figure 3). This proposal is consistent with
the proposed role of PKC activation (a downstream effect of the activation of the inositol
phosphate cascade) as a mediator of the changes in aromatase and other ovarian genes that
occur at high densities of the LHR (i.e., during luteinization, see refs. 26, 28, 56, 57). It should
also be noted that although a relationship between PKC activation and inhibition of aromatase
expression has been shown in granulosa cells (26), our results show for the first time a direct
association between the activation of the inositol phosphate cascade (induced here by
expression of a constitutively active Gαq, see Figure 4) and the suppression of aromatase. This
finding is important because although there is agreement about the ability of LH/CG to activate
the inositol phosphate cascade, there are conflicting reports on the ability of LH/CG to activate
PKC (37, 58). More studies are therefore needed to determine which of the two second
messengers generated by activation of the inositol phosphate cascade (inositol phosphates and
diacylglycerol) and which effectors of these second messengers are responsible for the
inhibition of the cAMP-and FSH-induced aromatase expression. Lastly, as noted here high
densities of the FSHR also result in a substantial suppression of the hFSH-induced aromatase
expression without a decrease in hFSH-induced cAMP accumulation (Figures 5–7).
Interestingly this suppression of aromatase expression is also associated with a modest increase
in the ability of hFSH to stimulate the inositol phosphate cascade. Therefore it is possible that
this hFSH-induced activation of the inositol phosphate cascade is also responsible for the
suppression of aromatase expression that occurs at high levels of FSHR expression.
More definitive proof for the proposed role of the inositol phosphate cascade as an inhibitor
of aromatase expression at high densities of the LHR or FSHR can be obtained only by showing
that inhibition of the inositol phosphate cascade prevents the suppression of aromatase
observed under these conditions. Although pharmacological inhibitors of phospholipase C and
PKC are available we have, so far, been unable to use them to further test our hypothesis
because of their toxicity. We are now attempting to design gene-silencing approaches to address
this important question. We also need to systematically determine if there are other signaling
cascades that become activated by gonadotropins acting on a high density of receptors and if
they are inhibitory to the cAMP-induced expression of aromatase.
Another novel and interesting finding reported here is that expression of increasing densities
of the recombinant hLHR have a negative impact on the cAMP response (Figure 2a) and on
aromatase induction (Figure 3) provoked when hFSH activates the endogenous FSHR. This
negative effect on hFSH signaling occurs without changes in the density of the endogenous
FSHR (Figure 1), is not general because it does not affect the hFSH-induced Akt
phosphorylation (Figure 2c), and it is not due to the activation of the recombinant hLHR
because it is observed in cells that have not been exposed to hCG. Moreover, since the reduction
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in the hFSH-induced cAMP response attained in cells expressing high densities of hLHR is
small (Figure 2a) it appears unlikely that this decrease would be solely responsible for the large
decrease in aromatase induction (Figure 3). This finding needs to be further investigated but
several explanations may be considered. First, since we know that GPCRs in general (59, 60)
and the hLHR in particular (40) have some intrinsic level of basal activity, it is easy to envision
how an increase in the density of the recombinant hLHR may increase the basal activation of
signaling pathways that impair the ability of the FSHR to induced aromatase experssion. This
is specially true if the signaling pathways involved in the induction of aromatase (such as cAMP
and/or phospho-Akt) are already maximally or near maximally activated by engaging the
endogenous FSHR. The reduced signaling ability of the endogenous FSHR in cells expressing
high hLHR densities may also result from increased dimerization between the endogenous
FSHR and the recombinant hLHR. Precedence of this exists with other GPCRs such as the
different subtypes of opioid receptors (61, 62). Finally, we (63) and others (64, 65) have
reported that the LHR and FSHR can each associate with at least one distinct protein that affects
signal transduction. Thus, the increased expression of either receptor could bring increasing
amounts of these associating proteins to the plasma membrane where they could affect
homologous or heterologous signaling.
In summary, we show that the differential effects of FSH and LH on aromatase in immature
granulosa cells are highly dependent on gonadotropin receptor density and on the signaling
pathways activated. We propose that aromatase is induced by common signals generated by
activation of the FSHR and LHR (either cAMP accumulation alone or a combination of cAMP
accumulation and Akt phosphorylation) and that activation of the inositol phosphate cascade
in cells expressing a high density of LHR or FSHR antagonizes this induction.
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Figure 1. 125I-hFSH and 125I-hCG binding to immature granulosa cells infected with different
amounts of Ad-hLHR.
Primary cultures of immature granulosa cells were infected with adenoviral constructs coding
for Ad-βgal at 200 MOI (labeled βgal in the figure), a mixture of hLHR at 20 MOI plus Ad-
βgal at 180 MOI (labeled hLHR-MOI 20) or Ad-hLHR at 200 MOI (labeled hLHR-MOI 200).
The binding of 125I-hFSH (left panel) or 125I-hCG (right panel) were measured 2 days after
infection as described in Materials and Methods.
Each bar is the mean ± SEM of 5–10 independent experiments. Means within a panel with
different letters (a, b) are significantly different from each other (P<0.05).
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Figure 2 . Human FSH- and hCG-induced cAMP, inositol phosphates and phospho Akt responses
in immature granulosa cells infected with different amounts of Ad-hLHR.
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Primary cultures of immature granulosa cells were infected with adenoviral constructs as
described in the legend to Figure 1. Two days after infection the cells were incubated with
buffer only (left panel), hFSH (middle panel) or hCG (right panel) and the resulting cAMP
(panel a), inositol phosphate (panel b) and phospho Akt responses (panel c) were measured as
described in Materials and Methods.
For ease of comparison with other figures, and in order to avoid the inherent variability in
absolute values associated with the use of primary cultures, all data are expressed relative to
the hFSH-induced response of cells infected with βgal (see white bar in the middle panel).
Each bar is the mean ± SEM of 4–11 independent experiments. Means within a panel with
different letters (a, b, c) are significantly different from each other (P<0.05). The relevant area
of representative Western blots documenting the effects of FSH and hCG on Akt
phosphorylation are also shown on the top of panel c.
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Figure 3 . Human FSH- and hCG-induced aromatase mRNA in immature granulosa cells infected
with different amounts of Ad-hLHR.
Primary cultures of immature granulosa cells were infected with adenoviral constructs as
described in the legend to Figure 1. Two days after infection cells were incubated with buffer
only (left panel), hFSH (middle panel) or hCG (right panel). Total RNA was then collected
and used to quantify aromatase mRNA using reverse transcription followed by real-time PCR,
as described in Materials and Methods.
For ease of comparison with other figures, and in order to avoid the inherent variability in
absolute values associated with the use of primary cultures, all data are expressed relative to
the hFSH-induced aromatase response of cells infected with βgal (see white bar in the middle
panel). The levels of aromatase mRNA in cells incubated with buffer only were often
undetectable (see left panel). Each bar is the mean ± SEM of 4–11 independent experiments.
Means within a panel with different letters (a, b, c) are significantly different from each other
(P<0.05).
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Figure 4 . Effects of the constitutively active Gαq mutant (GqQ209L) and a pharmacological
activator of PKC (PMA) on FSH- and 8BrcAMP-induced aromatase mRNA in immature granulosa
cells.
Primary cultures of immature granulosa cells were infected with 200 MOI Ad-βgal (labeled
βgal in the figure) or a mixture of 0.5 MOI Ad-GqQ209L and 199.5 MOI (labeled GqQ209L
in the figure). Two days later they were incubated with buffer only, hFSH 8BrcAMP, hFSH +
PMA or 8Br-cAMP + PMA as shown. Total RNA was then collected and used to quantify
aromatase mRNA using reverse transcription followed by real-time PCR, as described in
Materials and Methods.
For ease of comparison with other figures, and in order to avoid the inherent variability in
absolute values associated with the use of primary cultures, all data are expressed relative to
the hFSH-induced aromatase response of cells infected with βgal. The levels of aromatase
mRNA in cells incubated with buffer only were often undetectable. Each bar is the mean ±
SEM of 5–13 independent experiments. An asterisk indicates a statistically significant
difference (P < 0.05) between grouped cells (i.e., those infected with Ad-Gq209L and those
infected with Ad-βgal or those infected with Ad-βgal only and incubated with or without PMA)
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Figure 5. 125I-hFSH and 125I-hCG binding to immature granulosa cells after infection with
different amounts of Ad-hFSHR.
Primary cultures of immature granulosa cells were infected with adenoviral constructs coding
for Ad-βgal at 200 MOI (labeled βgal in the figure), a mixture of hFSHR Ad-βgal at 20 MOI
plus Ad-βgal at 180 MOI (labeled hFSHR-MOI 20) or Ad-hFSHR at 200 MOI (labeled hFSHR-
MOI 200). The binding of 125I-hFSH (left panel) or 125I-hCG (right panel) were measured 2
days after infection as described in Materials and Methods.
Each bar is the mean ± SEM of 5–9 independent experiments. Means within a panel with
different letters (a, b, c) are significantly different from each other (P<0.05).
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Figure 6 . Human FSH- and hCG-induced cAMP, inositol phosphates and phospho Akt responses
in immature granulosa cells infected with different amounts of Ad-hFSHR.
Primary cultures of immature granulosa cells were infected with adenoviral constructs as
described in the legend to Figure 5. Two days after infection the cells were incubated with
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buffer only (left panel), hFSH (middle panel) or hCG (right panel) and the resulting cAMP
(panel A), inositol phosphate (panel B), or phospho Akt responses (panel C) were measured
as described in Materials and Methods.
For ease of comparison with other figures, and in order to avoid the inherent variability in
absolute values associated with the use of primary cultures, all data are expressed relative to
the hFSH-induced response of cells infected with βgal (see white bar in the middle panel).
Each bar is the mean ± SEM of 5–11 independent experiments. Means within a panel with
different letters (a, b) are significantly different from each other (P<0.05). The relevant area
of representative Western blots documenting the effects of FSH and hCG on Akt
phosphorylation are also shown on the top of panel c.
Donadeu and Ascoli Page 22
Endocrinology. Author manuscript; available in PMC 2005 October 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7 . Human FSH- and hCG-induced aromatase mRNA in immature granulosa cells infected
with different amounts of Ad-hFSHR.
Primary cultures of immature granulosa cells were infected with adenoviral constructs as
described in the legend to Figure 5. Two days after infection cells were incubated with buffer
only, hFSH (middle panel) or hCG (right panel). Total RNA was then collected and used to
quantify aromatase mRNA using reverse transcription followed by real-time PCR, as described
in Materials and Methods.
For ease of comparison with other figures, and in order to avoid the inherent variability in
absolute values associated with the use of primary cultures, all data are expressed relative to
the hFSH-induced aromatase response of cells infected with βgal (see white bar in the middle
panel). The levels of aromatase mRNA in cells incubated with buffer only were often
undetectable (see left panel). Each bar is the mean ± SEM of 3–5 independent experiments.
Means within a panel with different letters (a, b) are significantly different from each other
(P<0.05).
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Table 1
Effect of infection with Ad-GqQ209L on inositol phosphate, 125I-hFSH binding and cAMP responses in
immature granulosa cells
Adenoviral construct used for infection
Response measured βgal GqQ209L
Inositol phosphates accumulation (relative to βgal-infected cells)1 1.0 ± 0.0 9.8 ± 1.5*
125I-hFSH binding (ng/106 cells) 2 1.7 ± 0.1 2.0 ± 0.3
FSH-induced cAMP accumulation (relative to βgal-infected cells)
2
1.0 ± 0.0 0.9 ± 0.1
Immature granulosa cells were infected with 200 MOI of Ad-βgal or a mixture of 0.5 MOI of Ad-GqQ209L and 199.5 MOI of Ad-βgal. The assays shown
were performed 2 days after infection as described in Materials and Methods.
1
For the inositol phosphate assays the Ad-βgal-infected cells were stimulated with hFSH but the Ad-GqQ209L-infected cells were incubated with buffer
only. The asterisk denotes a statistically significant difference (P < 0.05) between the Ad-βgal- and the Ad-GqQ209L-infected cells.
2 125I-hFSH binding and hFSH-induced cAMP accumulation were measured as described in Materials and Methods. The results are not statistically
different (P > 0.1) between Ad-βgal- and Ad-GqQ209L-infected cells.
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